Initiation of AERIAL trial accelerated by successful first close of Series A1 financing LEU011 is first CAR-T candidate for the treatment of solid tumours to be manufactured at Great Ormond Street Hospital (GOSH) Enrolment continues in AERIAL trial with initial data for LEU011 expected in...
Read More Details
Finally We wish PressBee provided you with enough information of ( Leucid Bio Announces Treatment of First Patient in AERIAL Trial of NKG2D CAR-T Therapy LEU011 for Solid Tumours )
Also on site :
- Zelensky challenges Putin’s offer to meet after Russia ignores ceasefire demand
- Keir says ‘we cant live on an island of strangers’ as he overhauls migration & cracks down on deportation dodgers
- Taylor Swift and Travis Kelce Make First Public Appearance in Two Months